Clinical Knowledge Summaries (CKS) questionnaire

HTML/Media/Text

Optional

Organization: - Undisclosed -

Name: - Undisclosed -

Email: - Undisclosed -

Total responses: 11

Please select

	AALAND ISLANDS	AFGHANISTAN	ALBANIA	ALGERIA	AMERICAN SAMOA	ANDORRA	ANGOLA	ANGUILLA	ANTARCTICA	ANTIGUA AND BARBUDA	ARGENTINA	ARMENIA	ARUBA	AUSTRALIA	AUSTRIA	AZERBAIJAN	BAHAMAS	BAHRAIN	BANGLADESH	BARBADOS	BELARUS	BELGIUM	BELIZE	BENIN	BERMUDA	BHUTAN	BOLIVIA	BOSNIA AND HERZEGOWINA	BOTSWANA	BOUVET ISLAND	BRAZIL	BRITISH INDIAN OCEAN TERRITORY	BRUNEI DARUSSALAM	BULGARIA	BURKINA FASO	BURUNDI	CAMBODIA	CAMEROON	CANADA	CAPE VERDE	CAYMAN ISLANDS	CENTRAL AFRICAN REPUBLIC	CHAD	CHILE	CHINA	CHRISTMAS ISLAND	COCOS (KEELING) ISLANDS	COLOMBIA	COMOROS	"CONGO, Democratic Republic of (was Zaire)"	"CONGO, Republic of"	COOK ISLANDS	COSTA RICA	COTE D'IVOIRE	CROATIA (local name: Hrvatska)	CUBA	CYPRUS	CZECH REPUBLIC	DENMARK	DJIBOUTI	DOMINICA	DOMINICAN REPUBLIC	ECUADOR	EGYPT	EL SALVADOR	EQUATORIAL GUINEA	ERITREA	ESTONIA	ETHIOPIA	FALKLAND ISLANDS (MALVINAS)	FAROE ISLANDS	FIJI	FINLAND	FRANCE	FRENCH GUIANA	FRENCH POLYNESIA	FRENCH SOUTHERN TERRITORIES	GABON	GAMBIA	GEORGIA	GERMANY	GHANA	GIBRALTAR	GREECE	GREENLAND	GRENADA	GUADELOUPE	GUAM	GUATEMALA	GUINEA	GUINEA-BISSAU	GUYANA	HAITI	HEARD AND MC DONALD ISLANDS	HONDURAS	HONG KONG	HUNGARY	ICELAND	INDIA	INDONESIA	IRAN (ISLAMIC REPUBLIC OF)	IRAQ	IRELAND	ISRAEL	ITALY	JAMAICA	JAPAN	JORDAN	KAZAKHSTAN	KENYA	KIRIBATI	"KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF"	"KOREA, REPUBLIC OF"	KUWAIT	KYRGYZSTAN	LAO PEOPLE'S DEMOCRATIC REPUBLIC	LATVIA	LEBANON	LESOTHO	LIBERIA	LIBYAN ARAB JAMAHIRIYA	LIECHTENSTEIN	LITHUANIA	LUXEMBOURG	MACAU	"MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF"	MADAGASCAR	MALAWI	MALAYSIA	MALDIVES	MALI	MALTA	MARSHALL ISLANDS;MARTINIQUE	MAURITANIA	MAURITIUS	MAYOTTE	MEXICO	"MICRONESIA, FEDERATED STATES OF"	"MOLDOVA, REPUBLIC OF"	MONACO	MONGOLIA	MONTSERRAT	MOROCCO	MOZAMBIQUE	MYANMAR	NAMIBIA	NAURU	NEPAL	NETHERLANDS	NETHERLANDS ANTILLES	NEW CALEDONIA	NEW ZEALAND	NICARAGUA	NIGER	NIGERIA	NIUE	NORFOLK ISLAND	NORTHERN MARIANA ISLANDS	NORWAY	OMAN	PAKISTAN;PALAU	"PALESTINIAN TERRITORY, Occupied"	PANAMA	PAPUA NEW GUINEA	PARAGUAY	PERU	PHILIPPINES	PITCAIRN	POLAND	PORTUGAL	PUERTO RICO	QATAR	REUNION	ROMANIA	RUSSIAN FEDERATION	RWANDA	SAINT HELENA	SAINT KITTS AND NEVIS;SAINT LUCIA	SAINT PIERRE AND MIQUELON	SAINT VINCENT AND THE GRENADINES	SAMOA;SAN MARINO	SAO TOME AND PRINCIPE	SAUDI ARABIA	SENEGAL	SERBIA AND MONTENEGRO	SEYCHELLES	SIERRA LEONE	SINGAPORE	SLOVAKIA	SLOVENIA	SOLOMON ISLANDS	SOMALIA	SOUTH AFRICA	SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS	SPAIN	SRI LANKA	SUDAN	SURINAME	SVALBARD AND JAN MAYEN ISLANDS	SWAZILAND	SWEDEN	SWITZERLAND	SYRIAN ARAB REPUBLIC	TAIWAN;TAJIKISTAN	"TANZANIA, UNITED REPUBLIC OF"	THAILAND	TIMOR-LESTE	TOGO	TOKELAU	TONGA	TRINIDAD AND TOBAGO	TUNISIA	TURKEY	TURKMENISTAN	TURKS AND CAICOS ISLANDS	TUVALU	UGANDA	UKRAINE	UNITED ARAB EMIRATES	UNITED KINGDOM	UNITED STATES	UNITED STATES MINOR OUTLYING ISLANDS	URUGUAY	UZBEKISTAN	VANUATU	VATICAN CITY STATE (HOLY SEE)	VENEZUELA	VIET NAM	VIRGIN ISLANDS (BRITISH)	VIRGIN ISLANDS (U.S.)	WALLIS AND FUTUNA ISLANDS	WESTERN SAHARA	YEMEN	ZAMBIA	ZIMBABWE
Country	1 (8.33%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	6 (50.00%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (8.33%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	3 (25.00%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1 (8.33%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)	0 (0%)

Total responses: 12

Allow 'Others', May select more than one

Summary of Statistics

	Total
GP	1 (8.33%)
Nurse	2 (16.67%)
Pharmacist	2 (16.67%)
Others:	7 (58.33%)

Total responses: 12

Summary of Statistics

	Total
Most days	6 (50%)
Weekly	1 (8.33%)
Monthly	2 (16.67%)
Rarely	2 (16.67%)
Do not use CKS (If you select this answer please go straight to question 6)	1 (8.33%)

Total responses: 12

Summary of Statistics

	Total
Essential	3 (25%)
Very useful	5 (41.67%)
Useful	1 (8.33%)
Sometimes useful	2 (16.67%)
Rarely useful	1 (8.33%)

Total responses: 12

May select more than one

Summary of Statistics

	Total
For information about management when seeing patients	5 (41.67%)
For information about management before or after seeing patients	4 (33.33%)
To aid prescribing	0 (0%)
To answer clinical questions for other healthcare professionals	7 (58.33%)
To print patient information leaflets	4 (33.33%)
For continual professional development/professional examinations	3 (25%)
To develop protocols, patient group directions, clinical management plans, local guidelines	3 (25%)
For teaching or the development of training material	4 (33.33%)
Other	4 (33.33%)

Total responses: 12

Summary of Statistics

	Total
Yes	6 (50%)
No	3 (25%)
Unsure	3 (25%)

Total responses: 12

Allow 'Others', Optional, May select more than one

Summary of Statistics

	Total
Mobile access	2 (25%)
Subscription by clinical specialty	2 (25%)
Monthly subscription	1 (12.5%)
Others:	3 (37.5%)

Total responses: 8

Summary of Statistics

	Total
Strongly agree	1 (8.33%)
Agree	5 (41.67%)
Neither agree nor disagree	4 (33.33%)
Disagree	0 (0%)
Strongly disagree	0 (0%)
Have not looked at trial topics	2 (16.67%)

Total responses: 12

Summary of Statistics

	Total
Strongly agree	2 (16.67%)
Agree	3 (25%)
Neither agree nor disagree	6 (50%)
Disagree	1 (8.33%)
Strongly disagree	0 (0%)

Total responses: 12

Summary of Statistics

	Total
Strongly agree	1 (8.33%)
Agree	3 (25%)
Neither agree nor disagree	4 (33.33%)
Disagree	1 (8.33%)
Strongly disagree	3 (25%)

Total responses: 12

Allow 'Others', Optional, May select more than one

Summary of Statistics

	Total
Localised drug information	3 (42.86%)
Localised medical conditions	1 (14.29%)
Content in multiple languages	3 (42.86%)
Others:	3 (42.86%)

Total responses: 7

Optional

Language 2:: - Undisclosed -

Language 1:: - Undisclosed -

Total responses: 6

Optional

20th Sep, 8:02 pm	- Undisclosed -
22nd Jul, 5:38 pm	- Undisclosed -
20th Jul, 3:39 am	- Undisclosed -
19th Jun, 8:31 am	- Undisclosed -
19th Jun, 8:22 am	- Undisclosed -
19th Jun, 8:04 am	- Undisclosed -

Total responses: 6

Clinical Knowledge Summaries (CKS) questionnaire

HTML/Media/Text

1. If you wish to be entered into the prize draw for a $50 Amazon voucher please ensure that you provide your name and email address.

2. 1. In which country do you live/work?

Please select

3. 2. What is your profession?

Summary of Statistics

4. 3. Which best describes how often you use CKS when you are working? (Select only ONE answer)

Summary of Statistics

5. 4. How useful is CKS to you? (Select only ONE answer)

Summary of Statistics

6. 5. Why do you use CKS? (Select one or more answers)

Summary of Statistics

7. 6. Regardless of price, is there currently a CKS subscription option to suit your needs? (Select only ONE answer)

Summary of Statistics

8. 7. ...if No, what option(s) would you like to be available? (Select ALL that apply)

Summary of Statistics

9. 8. Do you think the trial facility (3 sample topics) allows you to understand the benefits of CKS prior to purchase? (Select only ONE answer)

Summary of Statistics

10. 9. Least Developed Countries (LDCs) are given free/subsidised access to CKS. Overall, do you think the service is fairly priced? (Select only ONE answer)

Summary of Statistics

11. 10. "My use of CKS is limited because it is not relevant to my locality" (Select only ONE answer)

Summary of Statistics

12. 11. ...if you agree to the above, what forms of customisation would you like to see? (Select one or more answers)

Summary of Statistics

13. 12. If you would like to access CKS in a different language, which language(s)?

14. Additional comments: